• In the media
  • Drug Companies Are Focusing on the Poor After...
Media - published on 24 Jun 2019

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Writing in The New York Times, Donald G. McNeil Jr. charts the progress made by pharmaceutical companies on access to medicine since the HIV/AIDS crisis of the late 1990s. Drawing on interviews with leading experts, as well as the Foundation’s recent 10-Year Analysis on this topic, McNeil identifies the factors driving change.

Back to top |